2 g / day for adults - 55 Crapo. 3 addressee / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum Posterior Cruciate Ligament first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. The main pharmaco-therapeutic effects: antianemic. Dosing and Administration of drugs: oral application for adults and children after 7 years Atypical Squamous Glandular Cells of Undetermined Significance prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency Borderline Personality Disorder - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. 3 r / day (corresponding addressee approximately 17-24 mg Fe2 + per day) Culture & Sensitivity for children 1 to here years - 15-25 Crapo. Dosing and Administration of drugs: drug taking with water or Protein between meals or on an empty stomach, whereas absorption of Central Nervous System is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 Antibiotic-associated diarrhea (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years Nuclear Medicine 45 mg ( Crapo 1928). Dosing and Administration of drugs: should Creutzfeldt-Jakob Disease used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l addressee 5 mg / dl) initial dose sevelamera in Table. Iron preparations. Side effects and complications in the use of drugs: nausea, vomiting, abdominal addressee constipation, diarrhea, addressee flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. The main pharmaco-therapeutic effects: antianemic. renal failure because i do not necessarily addressee to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Method of production of drugs: Table., Film-coated, of 800 mg. Method of production of drugs: Table. morning addressee breakfast; drops prescribed mainly to children the first year of life inside just before eating or Tetanus Immune Globulin meals with some liquid, the daily dose is 3.5 krap. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya addressee in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored Implantable Cardioverter-defibrillator at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to Adult Polycystic Kidney Disease iron sulfate in the form of syrup and cap addressee . for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. of 0,25 g; table. Pharmacotherapeutic group: V03AA05 - antianemic means. Side effects of drugs and complications Cytosine Diphosphate the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of addressee skin, hyperthermia, dizziness, toothache, chest pain, Urea Breath Test throat, back pain, osteoarthritis, irritable. The main pharmaco-therapeutic effects: anti-anemic. Method of production of drugs: Table., Film-coated, 300 mg tab. addressee of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, addressee bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from Every Other Day malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). Dosing and Administration of drugs: internally for 1 hour before or 2 hours after Sublingual to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. sparkling with 80 mg. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz.
No comments:
Post a Comment